Amneal PharmaceuticalsAMRX -0.49%63 Days Inventory is 141.49 as of Mar. 2026, which is 10% above its 10-year median of 129.02. GuruFocus rates AMRX with a GF Score™ of 63/100 and a GF Value™ of $7.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 916 Drug Manufacturers companies, Amneal Pharmaceuticals ranks better than 70.52% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Amneal Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amneal Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.86.
Amneal Pharmaceuticals (NAS:AMRX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Amneal Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amneal Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Amneal Pharmaceuticals Days Inventory Related Terms
Amneal Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Amneal Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMRX vs INDV, KNSA, LQDA: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Amneal Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amneal Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amneal Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Amneal Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amneal Pharmaceuticals (AMRX) has a Days Inventory of 141.49 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amneal Pharmaceuticals and its competitors. This is 10% above median its historical median of 129.02. Over the past decade, Amneal Pharmaceuticals' Days Inventory has ranged from 116.62 to 204.29. According to the industry distribution chart, Amneal Pharmaceuticals ranks #270 out of 916 companies in the Drug Manufacturers industry, placing it in the top 29.5%.
Is Amneal Pharmaceuticals' Days Inventory too high?
Amneal Pharmaceuticals' current Days Inventory of 141.49 is 10% above median its 10-year median of 129.02. Over the past 10 years, this metric has ranged from a low of 116.62 to a high of 204.29. The Drug Manufacturers industry median Days Inventory is 164.43. Amneal Pharmaceuticals' value of 141.49 is 14% below this industry median. Based on the distribution chart, Amneal Pharmaceuticals ranks #270 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Amneal Pharmaceuticals has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Amneal Pharmaceuticals' Days Inventory compare to INDV and KNSA?
According to the Drug Manufacturers industry distribution chart, Amneal Pharmaceuticals ranks #270 out of 916 companies for Days Inventory. This puts Amneal Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 164.43. Amneal Pharmaceuticals' value of 141.49 is 14% below this benchmark. Historically, Amneal Pharmaceuticals' own Days Inventory has ranged from 116.62 to 204.29 over the past decade. While the company's 10-year median is 129.02 vs. the industry median of 164.43, Amneal Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amneal Pharmaceuticals's current Days Inventory of 141.49 is 14% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amneal Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amneal Pharmaceuticals's current Days Inventory is 141.49, which is 10% above median its own 10-year median of 129.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amneal Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Amneal Pharmaceuticals (AMRX) is currently considered Significantly Overvalued. The stock's GF Value™ is $7.57, compared to a current price of $17.24 — trading 127.7% above its estimated fair value. The current Days Inventory is 141.49, which is 10% above median its 10-year median of 129.02 and 14% below the Drug Manufacturers industry median of 164.43. Amneal Pharmaceuticals' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Amneal Pharmaceuticals (AMRX), the current Days Inventory is 141.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amneal Pharmaceuticals (AMRX) Overvalued in 2026?
Based on GuruFocus' analysis, Amneal Pharmaceuticals stock appears to be overvalued.
The current stock price of $17.24 is trading 127.7% above its estimated GF Value™ of $7.57.
GuruFocus considers Amneal Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for AMRX:
Days Inventory: 141.49 (10% above median its 10-year median of 129.02)
GF Value™: $7.57 vs. price of $17.24 (127.7% above fair value)
Industry Position: 14% below the Drug Manufacturers median (#270 of 916)
No single metric tells the full story. See the AMRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
63GF Score
Get the complete analysis for AMRX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMRX has been successfully added to your 
